Holen Sie sich die Stockscreener-App
7.63
1.60%
0.12
Handel nachbörslich:
7.63
CorMedix Inc Aktie (CRMD) Neueste Nachrichten
CorMedix (CRMD) Is Down 35.4% After Cutting 2026 Revenue Outlook And Reshuffling Leadership - simplywall.st
CorMedix Faces A Hard Reset As CMS Reimbursement Headwinds Emerge (CRMD) - Seeking Alpha
Are Investors Undervaluing CorMedix (CRMD) Right Now? - Yahoo Finance
CorMedix Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Yahoo Finance
How Recent Q3 Updates Are Shaping The CorMedix (CRMD) Investment Story - Yahoo Finance
Why CorMedix (CRMD) Is Down 35.4% After Cutting 2026 Guidance And Revamping Its Leadership Structure - Yahoo Finance
CorMedix stock rises after-hours: CEO locks in chairman seat, bigger paycheck and rich severance - MSN
CorMedix Stock Rises After-Hours: CEO Locks In Chairman Seat, Bigger Paycheck And Rich Severance - Stocktwits
What sentiment indicators say about CorMedix Inc. stockJuly 2025 Levels & Technical Confirmation Alerts - ulpravda.ru
Truist Securities lowers CorMedix stock price target on weaker revenue outlook By Investing.com - Investing.com South Africa
Breakout Move: Will CorMedix Inc. stock maintain growth storyDay Trade & Growth Focused Investment Plans - ulpravda.ru
A Look At CorMedix (CRMD) Valuation After 2026 Guidance Shift And Executive Changes - Yahoo Finance
Why is CorMedix stock crashing today: is it worth buying on the dip? - CryptoRank
Truist Securities lowers CorMedix stock price target on weaker revenue outlook - Investing.com Australia
CorMedix shares fall as 2026 revenue outlook disappoints (update) - MSN
Cormedix: Market Overreaction to 2026 Guidance Creates Undervalued Buy Opportunity - TipRanks
Alibaba, Costco among market cap stock movers on Thursday - Investing.com
Why CorMedix stock crashed today and is it worth buying on the dip? - Invezz
Is CorMedix Inc. stock a top pick in earnings seasonJuly 2025 Analyst Calls & Stock Portfolio Risk Management - ulpravda.ru
CorMedix price target lowered to $16 from $20 at Truist - TipRanks
Will CorMedix Inc. stock maintain growth storyQuarterly Trade Report & Smart Money Movement Alerts - ulpravda.ru
CorMedix Inc. Stock (CRMD) Opinions on 2026 Revenue Guidance - Quiver Quantitative
Dow Jumps Over 250 Points; US Initial Jobless Claims Increase - Benzinga
ELVN Stock Shot Up 60% Today – What’s Driving The Rally? - Stocktwits
Is CorMedix Inc. (19KA) stock resilient in recession scenariosLong Setup & Safe Capital Investment Plans - ulpravda.ru
CorMedix shares slip after unveiling lower revenue outlook for 2026 - MSN
Why Did CRMD Stock Crash 28% Today? - Stocktwits
CEO Moves: Is CorMedix Inc. (19KA) stock resilient in recession scenariosJuly 2025 Macro Moves & Verified Swing Trading Watchlist - ulpravda.ru
CorMedix sees FY26 revenue $300M-$320M - TipRanks
Cormedix Issues Strong Preliminary Q4 Results, Updates Outlook - TipRanks
CorMedix stock falls after issuing 2026 revenue guidance By Investing.com - Investing.com Canada
Cormedix Therapeutics announces preliminary fourth quarter and full year 2025 results - MarketScreener
CorMedix sees Q4 revenue $127M, consensus $127.52M - TipRanks
CorMedix stock falls after issuing 2026 revenue guidance - Investing.com
Cormedix Therapeutics Announces Preliminary Fourth Quarter And Full Year 2025 Results - TradingView — Track All Markets
CorMedix reports $127 million Q4 revenue, provides 2026 outlook By Investing.com - Investing.com India
(CRMD) CorMedix Expects 2026 Revenue Range $300M to $320M, vs. FactSet Est of $435.7 - MarketScreener
CorMedix announces leadership changes with CEO taking chairman role - Investing.com
Earnings Flash (CRMD) CorMedix Posts Q4 Preliminary Net Revenue $127M, vs. FactSet Est of $128.3M - MarketScreener
CorMedix Therapeutics Announces Leadership and Board Updates - The Manila Times
CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates - The Manila Times
Drugmaker CorMedix makes its CEO board chair and hires new commercial chief - Stock Titan
Momentum Shift: Is CorMedix Inc stock a top momentum play2025 Pullback Review & Risk Adjusted Buy/Sell Alerts - moha.gov.vn
Is CorMedix (CRMD) Offering Opportunity After Recent Share Price Pullback? - simplywall.st
Can CorMedix Inc. (19KA) stock surprise with quarterly resultsInsider Trading Compliance & Fast Growing Trading Plans - ulpravda.ru
OTLK Stock Crashes 67% in a Week: Here's What You Need to Know - Finviz
Will CorMedix Inc. (19KA) stock benefit from infrastructure bill2026 world cup usa national team semifinals defensive leaders pressing system knockout prediction breakdown - ulpravda.ru
CorMedix (CRMD) upgraded to strong buy: Here's what you should know - MSN
Trading the Move, Not the Narrative: (CRMD) Edition - Stock Traders Daily
Is CorMedix Inc stock a top momentum play2025 Market Sentiment & Real-Time Price Movement Reports - moha.gov.vn
Ironwood Stock Rises 27% on Upbeat Revenue Guidance for 2026 - Finviz
Assessing CorMedix (CRMD) Valuation After Its Recent Share Price Momentum - simplywall.st
Cormedix director Dunton sells $260k in shares - Investing.com
Cormedix Inc (CRMD) Live Share Price, Invest From India - INDmoney
INSM Stock Up 78% in 6 Months: Here's What You Need to Know - Finviz
Aug PostEarnings: Will CELUW stock deliver consistent dividends2025 Big Picture & Consistent Growth Stock Picks - moha.gov.vn
Kyverna Therapeutics Stock Up 41% in a Month: Here's Why - The Globe and Mail
RARE, MREO Tank as Osteogenesis Study Fails to Meet Primary Endpoint - The Globe and Mail
CorMedix price target raised to $18 from $17 at H.C. Wainwright - MSN
Can CorMedix's Melinta acquisition aid growth beyond DefenCath? - MSN
MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026? - Finviz
Ocugen Stock Surges 75% Year to Date: What's in Store for 2026? - Finviz
Can CorMedix's Melinta Acquisition Aid Growth Beyond DefenCath? - sharewise.com
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):